Cancertame Ayurvedic Formulation
Genesis of Cancer
Primary cancers of the liver include:
Hepatocellular carcinoma is the most common primary liver cancer comprising about 90 percent of all primary cancers of the liver. Hepatocellular carcinoma is more common in males as compared to females. Incidence of the hepatocellular carcinoma is higher in Asia and Africa. Studies have shown that carriers of hepatitis B and hepatitis C viruses have hundred times higher risk of hepatocellular carcinoma. Cirrhosis of the liver (hereditary or alcoholic) is another major risk factor. The food containing aflatoxins, nitrogenous compounds and arsenic may lead to genesis of the hepatocellular carcinoma.
Jaundice is the most common symptom of hepatocellular carcinoma. Other symptoms include abdominal pain, abdominal distension, weakness, weight loss, and cachexia. Hepatocellular carcinoma may present as a solitary mass or multiple scattered nodules in the liver. A bruit can be heard while auscultating over the liver area because the hepatocellular carcinoma is a highly vascular tumor. Sometimes, the hepatocellular carcinoma presents with a massive intraperitoneal haemorrhage. There may be portal or hepatic vein thrombosis leading to ascites. Systemic manifestations such as hypoglycaemia and hypercalcaemia may occur. In most of the cases, serum alpha-fetoprotein (AFP) the level is raised. Hepatocellular carcinoma is usually detected in advanced stages of the disease. A sudden deterioration of condition in the patient suffering from liver cirrhosis should always be suspected of hepatocellular carcinoma.
Staging of the hepatocellular carcinoma is done as follows:
Procedures used in the diagnosis and evaluation of the hepatocellular carcinoma include ultrasound, CT scan, estimation of serum AFP, angiography, bone scan, laparoscopy, and biopsy.
This content is for information and educational purposes only and should not be perceived as medical advice. Please consult a certified medical or healthcare professional before making any decision regarding your health using the content above.
Click here to go back to the list of all Articles
Dear Chapili Wasu, Cancertame can be taken in case of Stage 2 Uterus Cancer in a recommended dose of 1 capsule, 3 times a day as a palliative treatment only. For any other information you can write us back at firstname.lastname@example.org Regards, Support Team